TransAct Technologies (TACT)
(Delayed Data from NSDQ)
$4.55 USD
-0.07 (-1.52%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $4.60 +0.05 (1.10%) 4:38 PM ET
4-Sell of 5 4
B Value A Growth C Momentum A VGM
Income Statements
Fiscal Year end for TransAct Technologies Incorporated falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 73 | 58 | 39 | 31 | 46 |
Cost Of Goods | 34 | 34 | 24 | 18 | 24 |
Gross Profit | 38 | 24 | 15 | 13 | 22 |
Selling & Adminstrative & Depr. & Amort Expenses | 33 | 32 | 25 | 21 | 22 |
Income After Depreciation & Amortization | 6 | -8 | -10 | -8 | 0 |
Non-Operating Income | 1 | 0 | 3 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 6 | -8 | -6 | -8 | 0 |
Income Taxes | 1 | -2 | -2 | -3 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 5 | -6 | -4 | -6 | 1 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 5 | -6 | -4 | -6 | 1 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 7 | -6 | -9 | -7 | 2 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 1 | 1 |
Income After Depreciation & Amortization | 6 | -8 | -10 | -8 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 10.02 | 9.91 | 9.30 | 7.83 | 7.68 |
Diluted EPS Before Non-Recurring Items | 0.59 | -0.60 | -0.81 | -0.72 | 0.07 |
Diluted Net EPS (GAAP) | 0.47 | -0.60 | -0.45 | -0.72 | 0.07 |
Fiscal Year end for TransAct Technologies Incorporated falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 13.27 | 17.19 | 19.91 | 22.27 |
Cost Of Goods | NA | 6.89 | 8.27 | 9.05 | 10.02 |
Gross Profit | NA | 6.37 | 8.92 | 10.86 | 12.26 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 6.89 | 7.73 | 9.64 | 8.44 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -0.52 | 1.19 | 1.22 | 3.82 |
Non-Operating Income | NA | 0.47 | -0.04 | 0.00 | 0.02 |
Interest Expense | NA | 0.10 | 0.07 | 0.07 | 0.07 |
Pretax Income | NA | -0.10 | 1.08 | 1.16 | 3.77 |
Income Taxes | NA | -0.03 | 0.17 | 0.39 | 0.63 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -0.06 | 0.91 | 0.77 | 3.14 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -0.06 | 0.91 | 0.77 | 3.14 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 9.96 | 10.05 | 10.02 | 10.04 |
Diluted EPS Before Non-Recurring Items | NA | -0.01 | 0.09 | 0.22 | 0.31 |
Diluted Net EPS (GAAP) | NA | -0.01 | 0.09 | 0.08 | 0.31 |